GSK makes $2bn bet on liver drug from US biotech Posted on May 14, 2025 By The Times 2 Views GSK makes $2bn bet on liver drug from US biotech UK pharmaceutical company buys potential ‘best-in-class’ blockbuster from Boston Pharmaceuticals continue reading...